Last updated 2026-07-26
- Raised $9M Series B led by New Age Ventures, Sep 2022
- Raised $540k convertible note led by Robin Hood Ventures, Apr 2024
- Raised $2.7M convertible note led by MEDA Angels, Nov 2020
Total raised
$16.9M
Last: Undisclosed Round 2024-05
Stage
Series B
Founded
2010
Headcount
30
HQ
Newark, United States
Sector
Health Tech & Life Sciences
About
FEMSelect is a women-led medical technology company dedicated to advancing care for pelvic floor disorders. Its lead technology, EnPlace®, is a minimally invasive, mesh-free system for pelvic organ prolapse with strong safety and durability data. The company also offers Elitone® for non-surgical incontinence treatment. FEMSelect is committed to improving women's quality of life by providing innovative, patient-centered approaches to common conditions affecting women's health. The company was originally based in Israel and relocated its headquarters to the United States in May 2025.
Funding history · 7 rounds · $16.9M total
2024-04
Convertible Debt
$540K
★ Robin Hood Ventures
2022-09
B Round
$9.0M
★ New Age VenturesRAD BioMedMEDA AngelsTriventuresRobin Hood VenturesMid Atlantic Bio AngelsKeiretsu Forum NorthwestKeiretsu Capital Co-Investment Fund
2020-11
Convertible Debt
$2.7M
★ MEDA Angels★ Backswing Ventures★ Robin Hood Ventures
2019-11
Convertible Debt
$900K
★ Triventures★ Nava Zisapel★ Yehuda Zisapel (Late)★ Laguna Cliffs Capital★ Mid Atlantic Bio Angels★ Transpacific Medtech Fund★ Keiretsu Capital Co-Investment Fund
2017-04
A Round
$3.0M
★ Mid Atlantic Bio Angels
2012-11
Seed
Undisclosed
★ RAD BioMed★ Triventures
2011-12
Grant
$750K
Headcount over time
From 4 (2018-12) to 9 (2026-07) · +5 (+125%) · 17 points · source: Finder history + radar grounding
Q&A
- What is FEMSelect's primary focus?
- FEMSelect is a medical technology company focused on advancing care for pelvic floor disorders, particularly through its EnPlace® technology for pelvic organ prolapse treatment and Elitone® for non-surgical incontinence treatment.
- When did FEMSelect relocate its headquarters?
- FEMSelect relocated its headquarters from Israel to the United States in May 2025.
- Which investors participated in FEMSelect's October 2022 Series B funding round?
- In October 2022, FEMSelect raised $9,000,000 in Series B financing with participation from New Age Ventures and TriVentures.
- What is the employee count for FEMSelect?
- FEMSelect has 11-50 employees.
- What is the status of FEMSelect's EnPlace® technology?
- The EnPlace® system is FDA cleared and CE marked, and has been tested in a human trial in Israel. It is a minimally invasive, mesh-free system for pelvic organ prolapse.
- Who are the co-founders of FEMSelect?
- The co-founders of FEMSelect are Boaz Harari and Prof. Menahem Neuman.
- What is the total amount of funding FEMSelect has raised to date?
- FEMSelect has raised a total of $16,890,000 in funding.
Team · 2
Menachem Neuman
Founder · Medical Director
Boaz Harari
Founder · VP R&D
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
medical-devicesgynecologyminimally-invasivemedical-technologieswomen-healthdoctorssurgeonshospitalstreatmentsfemtech
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | femselect.com |
|---|---|
| linkedin.com/company/28632694 | |
| facebook.com/FEMSelect | |
| YouTube | youtube.com/channel/UCUXuID-G3yt22gTkPV8Ovuw |
Identifiers & details
| Former names | ProAcccess, Pop Medical Solutions |
|---|---|
| Founded | 2010 |
| Employees (exact) | 30 |
| Offices | Newark |
Radar intelligence
Patents
| EPO | 5 |
|---|
Web history (Wayback)
| Domain | femselect.com |
|---|
Certificate / subdomain footprint
| Subdomains | 9 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514809243 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2012-10-28 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 5 — annual_report (3), violation (1), people (1) |
| Registered address | המעיין 2 מודיעין-מכבים-רעות |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-04 | דו~ח שנתי-הקצאת מניות |
| 2026-06-04 | דו~ח שנתי-עדכון כתובת |
| 2026-06-04 | עדכון הפרה |
| 2026-06-04 | דו~ח שנתי-הפחתת הון מוקצה |
| 2026-06-02 | עדכון בעלי תפקידים |